| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/11/2009 | WO2009073180A2 Methods and compositions for modulating differentiation of pluripotential cells |
| 06/11/2009 | WO2009073178A1 Extracellular matrix from pluripotent cells |
| 06/11/2009 | WO2009072990A1 Method for extracellular matrix mediated differentiation and proliferation of stem cells |
| 06/11/2009 | WO2009072628A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 06/11/2009 | WO2009072626A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 06/11/2009 | WO2009072625A1 Amplification method for hematopoietic stem cells with heterocyclic compound |
| 06/11/2009 | WO2009072624A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 06/11/2009 | WO2009072609A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof |
| 06/11/2009 | WO2009072608A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof |
| 06/11/2009 | WO2009072588A1 Monoclonal antibody responsive to mouse polymeric immunoglobulin receptor |
| 06/11/2009 | WO2009072555A1 Cancer vaccine |
| 06/11/2009 | WO2009072003A2 Sample processing system and methods |
| 06/11/2009 | WO2009071920A2 Methods for identifying epigenetically silenced genes and novel tumour suppressor genes |
| 06/11/2009 | WO2009070872A1 Method of increasing erucic acid production by hairpin rna fad2 gene silencing and fae gene overexpression |
| 06/11/2009 | WO2009070842A1 Protection of progenitor cells and regulation of their differentiation |
| 06/11/2009 | WO2009019613A3 [nife]-hydrogenases having an improved resistance to dioxygen, process for obtaining them and their applications |
| 06/11/2009 | WO2007028106A3 Host cell lines for production of antibody constant region with enhanced effector function |
| 06/11/2009 | WO2006052551A3 Micromachined bilayer unit of engineered tissues |
| 06/11/2009 | WO2003024312A3 Cell therapy system |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | WO2002089727A3 Methods of using cytokine c17 |
| 06/11/2009 | WO2002047481A3 Direct application of desiccated entomopathogenic nematodes for biological pest control |
| 06/11/2009 | WO2002020717A3 Methods for simultaneous control of lignin content and composition, and cellulose content in plants |
| 06/11/2009 | US20090151029 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 06/11/2009 | US20090151027 Mortierella ramanniana DAGAT proteins; using such sequences to alter triacylglycerol levels in plants and to treat diseases associated with altered DAGAT activity or expression |
| 06/11/2009 | US20090151025 Indeterminate Gametophyte 1 (ig1), Mutations of ig1, Orthologs of ig1, and Uses Thereof |
| 06/11/2009 | US20090151021 Novel Stress-Related MicroRNA Molecules and Uses Thereof |
| 06/11/2009 | US20090151020 Chimeric and proline rich protein promoters for expression in plants |
| 06/11/2009 | US20090151019 Late blight resistance gene from wild potato |
| 06/11/2009 | US20090151018 Gdc-1 genes conferring herbicide resistance |
| 06/11/2009 | US20090151017 altering cellulose synthase concentration in the cell wall and thereby altering plant stalk quality for improved standability or silage |
| 06/11/2009 | US20090151016 Plants with increased hyaluronan production |
| 06/11/2009 | US20090151013 Modified ES cells and ES cell-specific genes |
| 06/11/2009 | US20090151011 Chimeric Non-Human Animal and Use Thereof |
| 06/11/2009 | US20090149642 Enriched preparation of human fetal multipotential neural stem cells |
| 06/11/2009 | US20090149637 Human antibodies derived from immunized xenomice |
| 06/11/2009 | US20090149636 Cytokine protein family |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149544 Alpha-aminoamide derivatives |
| 06/11/2009 | US20090149523 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases |
| 06/11/2009 | US20090149514 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/11/2009 | US20090149509 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium; 2 (S)-hydroxy-3 (R)-[2 (S)-oxazol-2-yl-pyrrolidine-1-carbonyl)-heptanoic acid hydroxamide |
| 06/11/2009 | US20090149449 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
| 06/11/2009 | US20090149414 rAAV EXPRESSION SYSTEMS AND COMPOSITIONS |
| 06/11/2009 | US20090149403 siRNA silencing of genes expressed in cancer |
| 06/11/2009 | US20090149401 Amide and peptide derivatives of tetraalkylenepentamines as transfection agents |
| 06/11/2009 | US20090149390 Oxidant resistant apolipoprotein a-1 and mimetic peptides |
| 06/11/2009 | US20090149389 Kinase Inhibitors And Uses Thereof |
| 06/11/2009 | US20090149381 Methods of regulating angiogenesis through stabilization of PEDF |
| 06/11/2009 | US20090149380 Vasostatin as marrow protectant |
| 06/11/2009 | US20090149372 bone morphogenic proteins; transforming growth factors; fusion proteins; drug screening; cardiovascular disorders |
| 06/11/2009 | US20090149365 Serine protease for enhancing washing performance of detergents; laundry and dishwashing; isolated from Bacillus strains |
| 06/11/2009 | US20090149336 Indexed library of cells containing genomic modifications and methods of making and utilizing the same |
| 06/11/2009 | US20090148948 Nucleic acids encoding a g-protein coupled receptor involved in taste transduction |
| 06/11/2009 | US20090148947 Flat microfibers as matrices for cell growth |
| 06/11/2009 | US20090148946 Separation system for cell, and cell culture system using separator for cell, and method of separation for cell |
| 06/11/2009 | US20090148945 Novel Biodegradable Elastomeric Scaffold for Tissue Engineering and Light Scattering Fingerprinting Methods for Testing the Same |
| 06/11/2009 | US20090148943 Agent for enhancing the production of cytokines and/or chemokines |
| 06/11/2009 | US20090148942 Humanized anti-cd70 binding agents and uses thereof |
| 06/11/2009 | US20090148941 Disposable mini-bioreactor device and method |
| 06/11/2009 | US20090148940 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 06/11/2009 | US20090148939 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 06/11/2009 | US20090148938 Method for identifying ester coolers |
| 06/11/2009 | US20090148937 Micro-fluidic system comprising an expanded channel |
| 06/11/2009 | US20090148925 Single chain class I major histocompatibility complexes |
| 06/11/2009 | US20090148921 Compositions and methods for enhancing apoptosis |
| 06/11/2009 | US20090148906 Optimized messenger rna |
| 06/11/2009 | US20090148905 Antigen-binding constructs |
| 06/11/2009 | US20090148904 Production of cytotoxic antibody-toxin fusion in eukaryotic algae |
| 06/11/2009 | US20090148903 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 06/11/2009 | US20090148902 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 06/11/2009 | US20090148901 Polypeptides having xylanase activity and polynucleotides encoding same |
| 06/11/2009 | US20090148900 Hemcm42 nucleic acids |
| 06/11/2009 | US20090148898 Human Ron-Related Gene Variant Associated With Cancers |
| 06/11/2009 | US20090148897 Human Ron-Related Gene Variant Associated With Cancers |
| 06/11/2009 | US20090148895 Method for Gene Amplification |
| 06/11/2009 | US20090148892 Novel methods |
| 06/11/2009 | US20090148888 Recombinant toxin fragments |
| 06/11/2009 | US20090148887 Genetically encoded boronate amino acid |
| 06/11/2009 | US20090148885 Fibroblast Growth Factor-Like Polypeptides |
| 06/11/2009 | US20090148880 Method and devices for treating individual biological cells |
| 06/11/2009 | US20090148878 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/11/2009 | US20090148876 Methods for the generation of cartilage-like material by mechanical loading |
| 06/11/2009 | US20090148867 Universal fluorescent sensors |
| 06/11/2009 | US20090148866 Antibodies and Improved Test Sample Handling Methods for Use in Assays for Myeloperoxidase |
| 06/11/2009 | US20090148855 Nucleic acid encoding or targeting sodium channel scn3a alpha subunits |
| 06/11/2009 | US20090148854 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 06/11/2009 | US20090148839 Method for evaluating cell populations |
| 06/11/2009 | US20090148507 Chimeric polypeptides containing chemokine domains |
| 06/11/2009 | US20090148471 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 06/11/2009 | US20090148465 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 06/11/2009 | US20090148461 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 06/11/2009 | US20090148457 Hepatocyte growth factor receptor antagonists and uses thereof |
| 06/11/2009 | US20090148456 Canine rankl and methods for preparing and using the same |
| 06/11/2009 | US20090148454 Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor |
| 06/11/2009 | US20090148453 Monoclonal antibodies against HMGB1 |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148449 Antibodies against cd38 for treatment of multiple myeloma |
| 06/11/2009 | US20090148448 Methods and compositions for modulating and detecting wisp activity |
| 06/11/2009 | US20090148441 Anti-Cancer Antibodies With Reduced Complement Fixation |